C-terminal truncation modulates -Synuclein’s cytotoxicity and aggregation by promoting the interactions with membrane and chaperone | Communications…

Benskey, M. J., Perez, R. G. & Manfredsson, F. P. The contribution of alpha synuclein to neuronal survival and function - implications for Parkinsons disease. J. Neurochem. 137, 331359 (2016).

CAS PubMed PubMed Central Google Scholar

Spillantini, M. G. et al. Alpha-synuclein in Lewy bodies. Nature 388, 839840 (1997).

CAS PubMed Google Scholar

Spillantini, M. G., Crowther, R. A., Jakes, R., Hasegawa, M. & Goedert, M. Alpha-Synuclein in filamentous inclusions of Lewy bodies from Parkinsons disease and dementia with Lewy bodies. Proc. Natl Acad. Sci. USA 95, 64696473 (1998).

CAS PubMed PubMed Central Google Scholar

Davidson, W. S., Jonas, A., Clayton, D. F. & George, J. M. Stabilization of alpha-synuclein secondary structure upon binding to synthetic membranes. J. Biol. Chem. 273, 94439449 (1998).

CAS PubMed Google Scholar

Bartels, T. et al. The N-terminus of the intrinsically disordered protein -synuclein triggers membrane binding and helix folding. Biophys. J. 99, 21162124 (2010).

CAS PubMed PubMed Central Google Scholar

Eliezer, D., Kutluay, E., Bussell, R. Jr. & Browne, G. Conformational properties of alpha-synuclein in its free and lipid-associated states. J. Mol. Biol. 307, 10611073 (2001).

CAS PubMed Google Scholar

Giasson, B. I., Murray, I. V., Trojanowski, J. Q. & Lee, V. M. A hydrophobic stretch of 12 amino acid residues in the middle of alpha-synuclein is essential for filament assembly. J. Biol. Chem. 276, 23802386 (2001).

CAS PubMed Google Scholar

Rodriguez, J. A. et al. Structure of the toxic core of -synuclein from invisible crystals. Nature 525, 486490 (2015).

CAS PubMed PubMed Central Google Scholar

Cho, M. K. et al. Structural characterization of alpha-synuclein in an aggregation prone state. Protein Sci. 18, 18401846 (2009).

CAS PubMed PubMed Central Google Scholar

Fernandez, C. O. et al. NMR of alpha-synuclein-polyamine complexes elucidates the mechanism and kinetics of induced aggregation. EMBO J. 23, 20392046 (2004).

CAS PubMed PubMed Central Google Scholar

Eliezer, D. The mysterious C-terminal tail of alpha-synuclein: Nanobodys guess. J. Mol. Biol. 425, 23932396 (2013).

CAS PubMed Google Scholar

Anderson, J. P. et al. Phosphorylation of Ser-129 is the dominant pathological modification of alpha-synuclein in familial and sporadic Lewy body disease. J. Biol. Chem. 281, 2973929752 (2006).

CAS PubMed Google Scholar

Muntane, G., Ferrer, I. & Martinez-Vicente, M. -Synuclein phosphorylation and truncation are normal events in the adult human brain. Neuroscience 200, 106119 (2012).

CAS PubMed Google Scholar

Bhattacharjee, P. et al. Mass spectrometric analysis of Lewy body-enriched -Synuclein in Parkinsons disease. J. Proteome Res. 18, 21092120 (2019).

CAS PubMed Google Scholar

Delcourt, V. et al. Spatially-resolved top-down proteomics bridged to MALDI MS imaging reveals the molecular physiome of brain regions. Mol. Cell. Proteom. 17, 357372 (2018).

CAS Google Scholar

Li, W. et al. Aggregation promoting C-terminal truncation of alpha-synuclein is a normal cellular process and is enhanced by the familial Parkinsons disease-linked mutations. Proc. Natl Acad. Sci. USA 102, 21622167 (2005).

CAS PubMed PubMed Central Google Scholar

Sorrentino, Z. A. et al. Physiological C-terminal truncation of -synuclein potentiates the prion-like formation of pathological inclusions. J. Biol. Chem. 293, 1891418932 (2018).

CAS PubMed PubMed Central Google Scholar

Murray, I. V. et al. Role of alpha-synuclein carboxy-terminus on fibril formation in vitro. Biochemistry 42, 85308540 (2003).

CAS PubMed Google Scholar

Iyer, A. et al. C-terminal truncated -Synuclein fibrils contain strongly twisted -sheets. J. Am. Chem. Soc. 139, 1539215400 (2017).

CAS PubMed PubMed Central Google Scholar

Levitan, K. et al. Conserved C-terminal charge exerts a profound influence on the aggregation rate of -synuclein. J. Mol. Biol. 411, 329333 (2011).

CAS PubMed PubMed Central Google Scholar

Ma, L. et al. C-terminal truncation exacerbates the aggregation and cytotoxicity of -Synuclein: A vicious cycle in Parkinsons disease. Biochim. Biophys. Acta, Mol. Basis Dis. 1864, 37143725 (2018).

CAS Google Scholar

Ni, X., McGlinchey, R. P., Jiang, J. & Lee, J. C. Structural insights into -synuclein fibril polymorphism: effects of Parkinsons disease-related C-terminal truncations. J. Mol. Biol. 431, 39133919 (2019).

CAS PubMed PubMed Central Google Scholar

van der Wateren, I. M., Knowles, T. P. J., Buell, A. K., Dobson, C. M. & Galvagnion, C. C-terminal truncation of -synuclein promotes amyloid fibril amplification at physiological pH. Chem. Sci. 9, 55065516 (2018).

PubMed PubMed Central Google Scholar

Sorrentino, Z. A., Xia, Y., Gorion, K. M., Hass, E. & Giasson, B. I. Carboxy-terminal truncations of mouse -synuclein alter aggregation and prion-like seeding. FEBS Lett. 594, 12711283 (2020).

CAS PubMed PubMed Central Google Scholar

McGlinchey, R. P. et al. C-terminal -synuclein truncations are linked to cysteine cathepsin activity in Parkinsons disease. J. Biol. Chem. 294, 99739984 (2019).

CAS PubMed PubMed Central Google Scholar

Terada, M. et al. The effect of truncation on prion-like properties of -synuclein. J. Biol. Chem. 293, 1391013920 (2018).

CAS PubMed PubMed Central Google Scholar

Games, D. et al. Reducing C-terminal-truncated alpha-synuclein by immunotherapy attenuates neurodegeneration and propagation in Parkinsons disease-like models. J. Neurosci. 34, 94419454 (2014).

PubMed PubMed Central Google Scholar

Ulusoy, A., Febbraro, F., Jensen, P. H., Kirik, D. & Romero-Ramos, M. Co-expression of C-terminal truncated alpha-synuclein enhances full-length alpha-synuclein-induced pathology. Eur. J. Neurosci. 32, 409422 (2010).

PubMed Google Scholar

Volpicelli-Daley, L. A. et al. Exogenous -synuclein fibrils induce Lewy body pathology leading to synaptic dysfunction and neuron death. Neuron 72, 5771 (2011).

CAS PubMed PubMed Central Google Scholar

Stephens, A. D. et al. Extent of N-terminus exposure of monomeric alpha-synuclein determines its aggregation propensity. Nat. Commun. 11, 2820 (2020).

CAS PubMed PubMed Central Google Scholar

Stefanova, N., Klimaschewski, L., Poewe, W., Wenning, G. K. & Reindl, M. Glial cell death induced by overexpression of alpha-synuclein. J. Neurosci. Res. 65, 432438 (2001).

CAS PubMed Google Scholar

Kanda, S., Bishop, J. F., Eglitis, M. A., Yang, Y. & Mouradian, M. M. Enhanced vulnerability to oxidative stress by alpha-synuclein mutations and C-terminal truncation. Neuroscience 97, 279284 (2000).

CAS PubMed Google Scholar

Bassil, F. et al. Reducing C-terminal truncation mitigates synucleinopathy and neurodegeneration in a transgenic model of multiple system atrophy. Proc. Natl Acad. Sci. USA 113, 95939598 (2016).

CAS PubMed PubMed Central Google Scholar

Daher, J. P. et al. Conditional transgenic mice expressing C-terminally truncated human alpha-synuclein (alphaSyn119) exhibit reduced striatal dopamine without loss of nigrostriatal pathway dopaminergic neurons. Mol. Neurodegener. 4, 34 (2009).

PubMed PubMed Central Google Scholar

Bertoncini, C. W. et al. Release of long-range tertiary interactions potentiates aggregation of natively unstructured alpha-synuclein. Proc. Natl Acad. Sci. USA 102, 14301435 (2005).

CAS PubMed PubMed Central Google Scholar

Dedmon, M. M., Lindorff-Larsen, K., Christodoulou, J., Vendruscolo, M. & Dobson, C. M. Mapping long-range interactions in alpha-synuclein using spin-label NMR and ensemble molecular dynamics simulations. J. Am. Chem. Soc. 127, 476477 (2005).

CAS PubMed Google Scholar

Auluck, P. K., Caraveo, G. & Lindquist, S. -Synuclein: membrane interactions and toxicity in Parkinsons disease. Annu. Rev. Cell Dev. Biol. 26, 211233 (2010).

CAS PubMed Google Scholar

Burmann, B. M. et al. Regulation of -synuclein by chaperones in mammalian cells. Nature 577, 127132 (2020).

CAS PubMed Google Scholar

Zhang, M. Y. & Beyer, C. E. Measurement of neurotransmitters from extracellular fluid in brain by in vivo microdialysis and chromatography-mass spectrometry. J. Pharm. Biomed. Anal. 40, 492499 (2006).

CAS PubMed Google Scholar

Watson, J. B. et al. Alterations in corticostriatal synaptic plasticity in mice overexpressing human alpha-synuclein. Neuroscience 159, 501513 (2009).

CAS PubMed Google Scholar

Dedmon, M. M., Christodoulou, J., Wilson, M. R. & Dobson, C. M. Heat shock protein 70 inhibits alpha-synuclein fibril formation via preferential binding to prefibrillar species. J. Biol. Chem. 280, 1473314740 (2005).

CAS PubMed Google Scholar

Gao, X. et al. Human Hsp70 disaggregase reverses parkinsons-linked -Synuclein amyloid fibrils. Mol. Cell 59, 781793 (2015).

CAS PubMed PubMed Central Google Scholar

Yagi-Utsumi, M., Satoh, T. & Kato, K. Structural basis of redox-dependent substrate binding of protein disulfide isomerase. Sci. Rep. 5, 13909 (2015).

PubMed PubMed Central Google Scholar

Wilkinson, B. & Gilbert, H. F. Protein disulfide isomerase. Biochim. Biophys. Acta 1699, 3544 (2004).

CAS PubMed Google Scholar

Bhattacharyya, D. et al. Multitude NMR studies of -synuclein familial mutants: probing their differential aggregation propensities. Chem. Commun. (Camb.) 54, 36053608 (2018).

CAS Google Scholar

Lee, H. J., Choi, C. & Lee, S. J. Membrane-bound alpha-synuclein has a high aggregation propensity and the ability to seed the aggregation of the cytosolic form. J. Biol. Chem. 277, 671678 (2002).

CAS PubMed Google Scholar

Robotta, M. et al. Alpha-synuclein binds to the inner membrane of mitochondria in an -helical conformation. Chembiochem 15, 24992502 (2014).

CAS PubMed Google Scholar

Cole, N. B., Dieuliis, D., Leo, P., Mitchell, D. C. & Nussbaum, R. L. Mitochondrial translocation of alpha-synuclein is promoted by intracellular acidification. Exp. Cell Res. 314, 20762089 (2008).

CAS PubMed PubMed Central Google Scholar

Nakamura, K. et al. Optical reporters for the conformation of alpha-synuclein reveal a specific interaction with mitochondria. J. Neurosci. 28, 1230512317 (2008).

CAS PubMed PubMed Central Google Scholar

Zigoneanu, I. G., Yang, Y. J., Krois, A. S., Haque, E. & Pielak, G. J. Interaction of -synuclein with vesicles that mimic mitochondrial membranes. Biochim. Biophys. Acta 1818, 512519 (2012).

CAS PubMed Google Scholar

Read the original:
C-terminal truncation modulates -Synuclein's cytotoxicity and aggregation by promoting the interactions with membrane and chaperone | Communications...